These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 6100156

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Total intracellular calcium content and sodium transport in erythrocytes of essential hypertensive patients.
    Engelmann B, Duhm J.
    J Hypertens Suppl; 1986 Dec; 4(6):S324-7. PubMed ID: 3475421
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Erythrocyte cation fluxes in essential hypertension of children and adolescents.
    Mongeau JG.
    Int J Pediatr Nephrol; 1985 Dec; 6(1):41-6. PubMed ID: 3997372
    [Abstract] [Full Text] [Related]

  • 10. Copper modifies the activity of sodium-transporting systems in erythrocyte membrane in patients with essential hypertension.
    Kedzierska K, Bober J, Ciechanowski K, Gołembiewska E, Kwiatkowska E, Noceń I, Dołegowska B, Dutkiewicz G, Chlubek D.
    Biol Trace Elem Res; 2005 Oct; 107(1):21-32. PubMed ID: 16170219
    [Abstract] [Full Text] [Related]

  • 11. [Transmembrane Na+ transport kinetics in arterial hypertension: relations with vascular risk parameters].
    Caballero Oliver A, Stiefel García-Junco P, García-Donas López MA, Villar Ortiz J, Carneado de la Fuente J.
    Med Clin (Barc); 1995 Dec 08; 105(20):768-73. PubMed ID: 8558976
    [Abstract] [Full Text] [Related]

  • 12. Clinical and biochemical approach of a circulating Na+-pump inhibitor.
    Devynck MA, de The H, Pernollet MG, Cloix JF, Rosenfeld JB, Kamal LA, Meyer P.
    J Physiol (Paris); 1984 Dec 08; 79(6):538-41. PubMed ID: 6152634
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Changes in erythrocyte contents of potassium, sodium and magnesium and Na, K-pump activity after the administration of potassium and magnesium salts.
    Sriboonlue P, Jaipakdee S, Jirakulsomchok D, Mairiang E, Tosukhowong P, Prasongwatana V, Savok S.
    J Med Assoc Thai; 2004 Dec 08; 87(12):1506-12. PubMed ID: 15822549
    [Abstract] [Full Text] [Related]

  • 18. [Circulating inhibitor of the Na+-K+ pump in essential hypertension. Physiological and pharmacological variations].
    Pernollet MG, de Thé H, Delva P, Wauquier I, Devynck MA, Baudouin-Legros M, Deray G, Rosenfeld J, Meyer P.
    Arch Mal Coeur Vaiss; 1984 Oct 08; 77(11):1283-7. PubMed ID: 6098238
    [Abstract] [Full Text] [Related]

  • 19. Altered erythrocyte cation transport related to hypertension or oral contraception.
    Stokes GS, Monaghan JC, Middleton A, Gunn J, Marwood JF.
    Klin Wochenschr; 1985 Oct 08; 63 Suppl 3():42-4. PubMed ID: 3999641
    [Abstract] [Full Text] [Related]

  • 20. Erythrocyte and plasma Ca2+, Mg2+ and cell membrane adenosine triphosphatase activity in patients with essential hypertension.
    Fu Y, Wang S, Lu Z, Li H, Li S.
    Chin Med J (Engl); 1998 Feb 08; 111(2):147-9. PubMed ID: 10374376
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.